Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Acquisitions (2016 - 2023)

Avanos Medical's Acquisitions history spans 5 years, with the latest figure at $2.1 million for Q4 2023.

  • For Q4 2023, Acquisitions changed N/A year-over-year to $2.1 million; the TTM value through Dec 2023 reached $49.6 million, down 57.28%, while the annual FY2025 figure was $28.0 million, N/A changed from the prior year.
  • Acquisitions for Q4 2023 was $2.1 million at Avanos Medical, down from $45.0 million in the prior quarter.
  • Across five years, Acquisitions topped out at $116.7 million in Q1 2022 and bottomed at -$4.0 million in Q4 2020.
  • The 4-year median for Acquisitions is $3.2 million (2020), against an average of $27.0 million.
  • The largest annual shift saw Acquisitions crashed 92.08% in 2020 before it skyrocketed 7600.0% in 2023.
  • A 4-year view of Acquisitions shows it stood at $50.5 million in 2019, then crashed by 107.92% to -$4.0 million in 2020, then surged by 85.0% to -$600000.0 in 2022, then surged by 450.0% to $2.1 million in 2023.
  • Per Business Quant, the three most recent readings for AVNS's Acquisitions are $2.1 million (Q4 2023), $45.0 million (Q3 2023), and $2.5 million (Q2 2023).